Serological analysis of specific IgA to Chlamydia pneumoniae: Increased sensitivity of IgA antibody detection using prolonged incubation and high antigen concentration

APMIS

Volumn 108, Issue 5, 2000, Pages 357-362

  Gnarpe, Judy ^a,b   Sparr, Annika ^a,b   Nääs, Jessica ^a,b   Lundbäck, Annika ^a,b  

^a GÄVLE HOSPITAL   (Sweden)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antibody detection; Chlamydia pneumoniae; IgA; Serology

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DIAGNOSTIC VALUE; HUMAN; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0033919823     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-68.x     Document Type: Article

References (14)

1. 1. Chirgwin K, Roblin PM, Gelling M, Hammerschlag MR, Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis 1991;163:757-61.
2. 2. Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand J Infect Dis 1994;26:179-87.
3. 3. Falck G, Gnarpe J, Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and in children with infections of the respiratory tract. Pediatr Infect Dis J 1997;16:549-54.
4. 4. Grayston JT. Chlamydia pneumoniae, strain TWAR pneumonia. Annu Rev Med 1992;43:317-23.
5. 5. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease. Stroke 1999;30:299-305.
6. 6. Toss H, Gnarpe J, Gnarpe H, Siegbahn A, Lindahl B, Venge P, Wallentin L. Increased fibrinogen and C-reactive protein levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J 1998;19:570-7.
7. 7. Rassenti LZ, Kipps TJ. Immunoglobulin Genes. In: Rose NR, de Macario EC, Folds JD, Lane HC, Nakamura RM, editors. Manual of Clinical Laboratory Immunology. American Society for Microbiology, Washington, DC, 1997: 147-55.
8. 8. Falck G, Engstrand I, Gad A, Gnarpe J, Gnarpe H, Laurila A. Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis. Scand J Infect Dis 1997;29:585-9.
9. 9. Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970;70:367-74.
10. 10. Gabriel AS, Gnarpe H, Gnarpe J, Hallander H, Nyquist O, Martinsson A. The prevalence of chronic Chlamydia pneumoniae infection as detected by polymerase chain reaction in pharyngeal samples from patients with ischaemic heart disease. Eur Heart J 1998;19:1321-7.
11. 11. Jauhianinen T, Toumi T, Leinonen M, Kark JD, Saikku P. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations for Chlamydia pneumoniae by microimmunofluorescence test. J Clin Microbiol 1994;32:839-40.
12. 12. Ekman MR, Leinonen M, Syrjälä H, Linnanmäki E, Kujula P, Saikku P. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993; 12:756-60.
13. 13. Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25.
14. 14. Boman J, Söderberg S, Forsberg J, Slunga-Birgander L, Allard A, Persson K, Jidell E, Kumlin U, Juto P, Waldenström A, Wadell G. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998;178:274-7.